Nanologica
1,895
SEK
-1,56 %
NICA
NASDAQ Stockholm
Biotechnology & Pharmaceuticals
Health Care
1 investor følger denne virksomhed
-1,56%
+4,12%
-18,49%
-67,29%
-80,94%
-80,1%
-84,75%
-81,01%
-89,55%
Nanologica is a life science tools company that develops, manufactures and sells advanced consumables to pharmaceutical companies. Nanologica's silica-based products are specially designed for the purification of peptide drugs, such as insulin and GLP-1 analogs. Nanologica operates in a global niche market for medicines for the treatment of diabetes and obesity. Nanologica was founded in 2004 and has its headquarters in Södertälje.
Læs mereMarkedsværdi
167,44 mio. SEK
Aktieomsætning
72,95 t SEK
Omsætning
1,44 mio.
EBIT %
-4.858,33 %
P/E
-
Udbytteafkast, %
-
Finanskalender
7.2
2025
Årsrapport '24
17.4
2025
Delårsrapport Q1'25
22.5
2025
Generalforsamling '24
ViserAlle indholdstyper
Number of Shares and Votes in Nanologica AB (publ)
Redeye: Nanologica Q3 2024 - Poised for harvest season?
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools